Stock listing
Lang & Schwarz:A2QMUH Viridian Therapeutics, Inc. Aktie
German listing (Lang & Schwarz) of Viridian Therapeutics, Inc. · home listing NASDAQ:VRDN
Follow Viridian Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:VRDN
$22.43 USD +1.63 (+7.8%)
Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:VRDN
- Day range
- $20.85 – $22.68 USDOct 20, 2026
- Volume
- 1.97M sharesOct 20, 2026
- Market cap
- $2.54B USDAt the close on Oct 20, 2026 · price × 113.3M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VRDN · Home | $22.43 USD | +1.63 (+7.8%) | 1,974,478 | $21.10 | $22.68 | $20.85 | $20.80 | Close on Oct 20, 2026 |
| LSE:0K1R | $22.20 USD | +1.735 (+8.5%) | 785 | $21.08 | $22.27 | $20.64 | $20.47 | Close on Oct 20, 2026 |
| Frankfurt:1S1 | €18.40 EUR | +1.40 (+8.2%) | — | €18.40 | €18.40 | €18.40 | €17.00 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:VRDN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $22.43 | +1.63 | +7.8% | $21.10 | $22.68 | $20.85 | 1,974,478 | |
| $20.80 | +1.77 | +9.3% | $19.23 | $20.88 | $19.07 | 2,575,984 | |
| $19.03 | -0.53 | -2.7% | $19.67 | $19.78 | $18.94 | 2,457,260 | |
| $19.56 | +1.18 | +6.4% | $18.76 | $19.76 | $18.54 | 2,167,909 | |
| $18.38 | +0.16 | +0.9% | $18.19 | $18.75 | $18.01 | 3,732,880 | |
| $18.22 | -0.08 | -0.4% | $18.04 | $18.33 | $17.96 | 2,124,097 | |
| $18.30 | -0.36 | -1.9% | $19.00 | $19.19 | $18.21 | 1,946,521 | |
| $18.66 | +0.32 | +1.7% | $18.31 | $18.72 | $18.16 | 1,334,238 | |
| $18.34 | +0.06 | +0.3% | $18.02 | $18.44 | $17.59 | 2,443,771 | |
| $18.28 | +0.06 | +0.3% | $18.02 | $18.73 | $17.92 | 1,691,100 | |
| $18.22 | -0.78 | -4.1% | $19.00 | $19.13 | $18.07 | 2,195,800 | |
| $19.00 | -0.40 | -2.1% | $19.41 | $19.59 | $18.83 | 2,651,200 | |
| $19.40 | +0.41 | +2.2% | $19.16 | $19.55 | $18.92 | 1,515,400 | |
| $18.99 | -1.60 | -7.8% | $20.61 | $20.61 | $18.99 | 3,375,300 | |
| $20.59 | +0.595 | +3.0% | $20.27 | $20.75 | $20.00 | 1,404,800 | |
| $20.00 | -0.575 | -2.8% | $20.69 | $20.85 | $19.73 | 1,233,600 | |
| $20.57 | +0.10 | +0.5% | $20.31 | $20.71 | $20.03 | 1,339,100 | |
| $20.47 | -0.19 | -0.9% | $20.75 | $21.01 | $20.16 | 2,090,600 | |
| $20.66 | -0.77 | -3.6% | $21.10 | $21.25 | $20.22 | 2,211,300 | |
| $21.43 | -0.69 | -3.1% | $22.11 | $22.19 | $21.20 | 2,857,600 | |
| $22.12 | +0.54 | +2.5% | $22.02 | $22.33 | $21.54 | 1,456,700 | |
| $21.58 | -0.42 | -1.9% | $22.28 | $22.40 | $21.53 | 1,745,400 | |
| $22.00 | +0.07 | +0.3% | $21.99 | $22.17 | $21.80 | 5,381,500 | |
| $21.93 | -0.51 | -2.3% | $22.88 | $22.97 | $21.72 | 1,268,400 | |
| $22.44 | +0.61 | +2.8% | $21.89 | $22.46 | $21.68 | 1,671,900 | |
| $21.83 | -0.37 | -1.7% | $21.98 | $22.14 | $21.40 | 1,210,900 | |
| $22.20 | +0.96 | +4.5% | $21.47 | $22.30 | $21.27 | 1,300,800 | |
| $21.24 | -1.05 | -4.7% | $22.48 | $22.70 | $21.19 | 943,200 | |
| $22.29 | -0.44 | -1.9% | $22.40 | $22.60 | $21.99 | 1,310,100 | |
| $22.73 | -0.44 | -1.9% | $23.11 | $23.58 | $22.70 | 1,578,300 | |
| $23.17 | +0.25 | +1.1% | $22.38 | $23.84 | $22.22 | 1,829,300 | |
| $22.92 | -0.04 | -0.2% | $22.62 | $23.03 | $22.62 | 759,900 | |
| $22.96 | +0.18 | +0.8% | $23.08 | $23.28 | $22.57 | 1,193,800 | |
| $22.78 | -0.25 | -1.1% | $23.11 | $23.74 | $22.39 | 1,417,400 | |
| $23.03 | -0.13 | -0.6% | $23.02 | $23.34 | $22.89 | 998,400 | |
| $23.16 | +0.08 | +0.3% | $22.94 | $23.27 | $22.62 | 1,048,800 | |
| $23.08 | -0.80 | -3.4% | $23.58 | $23.70 | $23.04 | 778,900 | |
| $23.88 | -0.38 | -1.6% | $24.22 | $24.47 | $23.75 | 839,700 | |
| $24.26 | +0.08 | +0.3% | $24.16 | $24.46 | $23.92 | 780,800 | |
| $24.18 | +0.16 | +0.7% | $24.30 | $24.80 | $24.08 | 901,400 | |
| $24.02 | -0.27 | -1.1% | $24.35 | $24.39 | $24.00 | 1,131,100 | |
| $24.29 | -0.21 | -0.9% | $24.65 | $24.75 | $24.07 | 905,600 | |
| $24.50 | -0.30 | -1.2% | $24.61 | $24.72 | $23.96 | 1,076,000 | |
| $24.80 | +0.87 | +3.6% | $24.52 | $24.86 | $23.80 | 1,833,800 | |
| $23.93 | +0.84 | +3.6% | $23.00 | $23.95 | $22.84 | 1,992,400 | |
| $23.09 | +1.01 | +4.6% | $21.92 | $23.29 | $21.87 | 1,892,800 | |
| $22.08 | +0.09 | +0.4% | $22.00 | $22.23 | $21.62 | 1,093,300 | |
| $21.99 | -0.89 | -3.9% | $22.70 | $22.86 | $21.89 | 1,767,600 | |
| $22.88 | -0.09 | -0.4% | $23.16 | $23.60 | $22.72 | 1,578,300 | |
| $22.97 | -0.09 | -0.4% | $23.23 | $23.83 | $22.81 | 3,063,000 | |
| $23.06 | -0.53 | -2.2% | $23.46 | $23.57 | $22.78 | 2,268,300 | |
| $23.59 | +1.08 | +4.8% | $22.98 | $23.61 | $22.53 | 1,659,800 | |
| $22.51 | +1.44 | +6.8% | $20.94 | $22.52 | $20.53 | 4,289,600 | |
| $21.07 | +0.23 | +1.1% | $21.00 | $21.34 | $20.60 | 1,666,500 | |
| $20.84 | +1.53 | +7.9% | $19.43 | $20.89 | $19.41 | 2,170,200 | |
| $19.31 | +0.39 | +2.1% | $18.80 | $19.32 | $18.40 | 1,833,900 | |
| $18.92 | -0.98 | -4.9% | $19.66 | $19.90 | $18.89 | 1,088,000 | |
| $19.90 | +0.02 | +0.1% | $19.55 | $20.01 | $19.29 | 1,215,800 | |
| $19.88 | +0.37 | +1.9% | $19.56 | $19.99 | $19.15 | 2,045,300 | |
| $19.51 | -0.19 | -1.0% | $19.67 | $19.95 | $19.11 | 1,100,800 | |
| $19.70 | +0.43 | +2.2% | $19.57 | $20.10 | $19.35 | 2,224,400 | |
| $19.27 | +0.01 | +0.1% | $19.39 | $19.45 | $19.00 | 1,515,600 | |
| $19.26 | +0.09 | +0.5% | $18.87 | $19.60 | $18.61 | 1,346,600 | |
| $19.17 | -0.01 | -0.1% | $18.94 | $19.39 | $18.73 | 2,622,800 | |
| $19.18 | +0.62 | +3.3% | $18.58 | $19.27 | $18.48 | 1,116,800 | |
| $18.56 | +0.53 | +2.9% | $18.17 | $19.23 | $18.15 | 2,180,600 |
- Ticker
- Lang & Schwarz:A2QMUH
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Oct 20, 2026
Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026
Latest deck · Jun 29, 2026
Corporate Update (June 2026)
Corporate update · 28 slides
Calls
Replays
Viridian Therapeutics (NASDAQ:VRDN) Q4 2024 Earnings Call
Wed, Mar 12, 2025 · 10:00 AM ET
Watch TranscriptViridian Therapeutics (NASDAQ:VRDN) Q1 2024 Earnings Call
Wed, May 08, 2024 · 8:00 AM ET
Watch TranscriptViridian Therapeutics (NASDAQ:VRDN) Q1 2023 Earnings Call
Tue, May 09, 2023 · 4:30 PM ET
Watch Transcript
Latest news
Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026
Oct 20, 2026
Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results
Aug 6, 2026
Closed $22.51 (+6.8%) on Aug 6, 2026
Raymond Douglas, MD, PhD, Is First in the Nation to Infuse Newly FDA-Approved Thyroid Eye Disease Treatment, LUMVOA ™ (veligrotug-vvze)
Jul 16, 2026
Closed $18.03 (-5.4%) on Jul 16, 2026
Bambusa Therapeutics Appoints Todd James Chief Financial Officer
Mar 19, 2026
Issued by another party
Decks
Corporate Update (June 2026)
Corporate update · 28 slides · Jun 29, 2026
Technical Presentation (May 2026)
Technical · 20 slides · May 5, 2026
Investor Presentation (May 2026)
Investor deck · 71 slides · May 5, 2026
Technical Presentation (March 2026)
Technical · 20 slides · Mar 30, 2026
Viridian Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 147 in all · newest Oct 20, 2026 · oldest 2019
- Calls
- 6 calls with a replay · 6 with a transcript · latest Mar 12, 2025
- Decks
- 21 decks · latest Jun 29, 2026
Where Viridian Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VRDN · Home listing | NASDAQ | United States | USD |
| gettex:1S1 | gettex | Germany | EUR |
| LS Exchange:A2QMUH | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2QMUH · This page | Lang & Schwarz | Germany | EUR |
| LSE:0K1R | LSE | United Kingdom | USD |
| Tradegate:1S1 | Tradegate | Germany | EUR |
| BOATS:VRDN | BOATS | United States | USD |
| Frankfurt:1S1 | Frankfurt | Germany | EUR |
| Dusseldorf:1S1 | Dusseldorf | Germany | EUR |
| Stuttgart:1S1 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Viridian Therapeutics, Inc.